• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

eMed Technologies postpones IPO plans

Article

eMed Technologies postpones IPO plansTeleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (PNN

eMed Technologies postpones IPO plans

Teleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (

PNN

9/99). Citing a volatile market and Wall Street’s recent apprehension about Internet stocks and the healthcare information systems sector in particular, the Lexington, MA-based company opted to delay the offering until the climate improves, according to John Strauss, vice president of marketing.

“This is a postponement,” Strauss said. “We will continue to look at the marketplace, and when the healthcare segment is valued differently, we will consider doing this again.”

eMed had hoped to raise more than $57 million through the IPO by selling 3.1 million stocks at $12 to $14/share. Combined with existing private shareholder equity, this would have placed the company’s market capitalization at $177 million.

eMed’s plans to move in a more Internet-based direction remain unchanged, according to Strauss. The company introduced a Web-based teleradiology and image distribution application earlier this year and plans to debut a new Web-based service for radiologists at the upcoming RSNA meeting.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.